The burgeoning virtual marketplace has presented novel avenues for accessing prescription substances, including the stimulant Adderall, primarily recommended for attention deficit hyperactivity disorder (ADHD). While supporters of cognitive enhancement argue that these substances can augment focus and productivity, ethical concerns surge surroundin